Tiziana Life Sciences delivers its fully human therapeutic antibody, foralumab, to the gut or nose mucosal surfaces aiming to modulate the immune response. This might help to control various autoimmune diseases such as Crohn’s and Multiple Sclerosis (MS).Foralumab has also been clinically tested wi
22 Sep 2021
Controlling disease using a safe, nasal and oral antibody
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Controlling disease using a safe, nasal and oral antibody
- Published:
22 Sep 2021 -
Author:
Robin Davison | John Savin PhD | Julian Hofmann -
Pages:
14
Tiziana Life Sciences delivers its fully human therapeutic antibody, foralumab, to the gut or nose mucosal surfaces aiming to modulate the immune response. This might help to control various autoimmune diseases such as Crohn’s and Multiple Sclerosis (MS).Foralumab has also been clinically tested wi